|
MedChemExpress
mapk activator anisomycin ![]() Mapk Activator Anisomycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc13459312-90-17-20 Average 97 stars, based on 1 article reviews
mapk activator anisomycin - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
TargetMol
anisomycin ![]() Anisomycin, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc12207439-98-11-13 Average 94 stars, based on 1 article reviews
anisomycin - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
jnk activator anisomycin ![]() Jnk Activator Anisomycin, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pm37149668-90-11-19 Average 95 stars, based on 1 article reviews
jnk activator anisomycin - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
hela cell lysates ![]() Hela Cell Lysates, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/HeLa+%2B+anisomycin+Cell+Lysate/10__1042_slash_bj20091383-81-7-27 Average 93 stars, based on 1 article reviews
hela cell lysates - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
anisomycin ![]() Anisomycin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc07055902-42-0-1 Average 93 stars, based on 1 article reviews
anisomycin - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Alomone Labs
anisomycin ![]() Anisomycin, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc11775629-138-24-25 Average 94 stars, based on 1 article reviews
anisomycin - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Tocris
protein synthesis inhibitor anisomycin ![]() Protein Synthesis Inhibitor Anisomycin, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc06416243-172-13-24 Average 95 stars, based on 1 article reviews
protein synthesis inhibitor anisomycin - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Tocris
anisomycin ![]() Anisomycin, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc12641031-251-15-31 Average 94 stars, based on 1 article reviews
anisomycin - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anisomycin am ![]() Anisomycin Am, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/pmc12347751-21-11-14 Average 93 stars, based on 1 article reviews
anisomycin am - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
nih 3t3 lysate ![]() Nih 3t3 Lysate, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/NIH%2F3T3+%2B+anisomycin+Cell+Lysate/pmc04698415-244-14-16 Average 90 stars, based on 1 article reviews
nih 3t3 lysate - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
k 562 ![]() K 562, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/K-562+%2B+anisomycin+Cell+Lysate/pmc04068500-50-14-20 Average 91 stars, based on 1 article reviews
k 562 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
BOC Sciences
anisomycin an ![]() Anisomycin An, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anisomycin/Anisomycin/10__1074_slash_jbc__m103315200-53-13-20 Average 90 stars, based on 1 article reviews
anisomycin an - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Ovarian Research
Article Title: Gut microbiota-derived Tryptophanol driven by N-Carbamylglutamate alleviates premature ovarian failure through inhibiting oxidative stress
doi: 10.1186/s13048-026-02152-4
Figure Lengend Snippet: Tryptophanol treatment alleviated POF symptoms by inhibiting PI3K/AKT and MAPK pathways. A Experimental scheme. B Estrus status of mice ( n = 8). C Body weights of mice ( n = 8). D Ovary weights of mice ( n = 8). E Representative Ovary from the Control, the POF and the NCG groups mice with H&E and IHC staining. H&E scale bar = 200 μm; IHC scale bar = 100 μm. F Quantification of primordial, primary, secondary, antral follicles, corpora lutea and corpora atretica per ovary. n = 3 ovaries per each condition. Levels of FSH ( G ), LH ( H ), E 2 ( I ) in mouse serum ( n = 6). Levels of ROS ( J ), MDA ( K ), SOD ( L ), GSH-Px ( M ) in mouse ovaries ( n = 3–4). N Western blotting ( a ) and quantitative ( b ) analysis of proteins ( n = 3). O Litter sizes of mice ( n = 3). Data presented as the mean ± SD, statistical significance was determined using one-way or two-way ANOVA. * p < 0.05, ** p < 0.01. *** p < 0.001. Different lowercase letters indicate significant differences ( p < 0.05)
Article Snippet: To investigate the role of specific signaling pathways, the AKT activator SC79 (MCE, 5 μg/mL) or the
Techniques: Control, Immunohistochemistry, Western Blot
Journal: Journal of Ovarian Research
Article Title: Gut microbiota-derived Tryptophanol driven by N-Carbamylglutamate alleviates premature ovarian failure through inhibiting oxidative stress
doi: 10.1186/s13048-026-02152-4
Figure Lengend Snippet: Tryptophanol treatment alleviated POF by inhibiting PI3K/AKT and MAPK pathways in vitro . A Experimental scheme. B Different concentrations of Cy on GCs viability was assessed by CCK8 assay. C and E Different concentrations of Trp on GCs viability was assessed by CCK8 assay. D The effect of Trp on GCs cell viability following Cy treatment. The control and treatment groups were stained with DCFH-DA, the cells were washed and examined by fluorescence microscopy. Scale bar = 50 μm. F The fluorescence intensity of ROS in mouse GCs. G The level of MDA in mouse GCs. H Flow cytometry apoptosis analysis graph and cell death rate in different groups. The level of SOD ( I ), GSH-Px ( J ), and E 2 ( K ) in mouse GCs. ( L ) Western blotting ( a ) and quantitative ( b ) analysis of proteins ( n = 3). All values are presented as the mean ± SD ( n = 3). Different lowercase letters indicate significant differences compared to the control group ( p < 0.05)
Article Snippet: To investigate the role of specific signaling pathways, the AKT activator SC79 (MCE, 5 μg/mL) or the
Techniques: In Vitro, CCK-8 Assay, Control, Staining, Fluorescence, Microscopy, Flow Cytometry, Western Blot
Journal: Journal of Ovarian Research
Article Title: Gut microbiota-derived Tryptophanol driven by N-Carbamylglutamate alleviates premature ovarian failure through inhibiting oxidative stress
doi: 10.1186/s13048-026-02152-4
Figure Lengend Snippet: Activation of MAPK pathway abrogated the protective effect of Tryptophanol against POF in vitro . A Cell viability of mouse GCs. B Flow cytometry apoptosis analysis graph and cell death rate in different groups. C The level of MDA in mouse GCs. The level of SOD ( D ), GSH-Px ( E ), and E 2 ( F ) in mouse GCs. G Western blotting (a) and quantitative ( b ) analysis of proteins ( n = 3). All values are presented as the mean ± SD ( n = 3). Different lowercase letters indicate significant differences compared to the control group ( p < 0.05)
Article Snippet: To investigate the role of specific signaling pathways, the AKT activator SC79 (MCE, 5 μg/mL) or the
Techniques: Activation Assay, In Vitro, Flow Cytometry, Western Blot, Control
Journal: BMB Reports
Article Title: LPS stimulation-induced regulation of LECT2 expression via TLR4 in hepatocytes
doi: 10.5483/BMBRep.2025-0046
Figure Lengend Snippet: LPS induces expression of LECT2 in hepatocytes by TLR4-mediated p38 MAPK activation. (A) Expression of LECT2 protein in AML12 cells treated with PD98059 (a MEK inhibitor 3 μM), SB203580 (p38 inhibitor, 3 μM), SP600125 (JNK inhibitor, 3 μM), Bay11-7082 (NF-κB inhibitor 3 μM) and LY294002 (PI3K inhibitor 3 μM) for 1 h, and then treated with or without LPS (1 μg/ml) for 6 h. (B) LPS activates p38, and LPS-activated p38 was reduced by p38 inhibitor in hepatocytes. AML12 cells were treated with LPS (1 μg/ml) for the designated times. AML12 cells were incubated for 6 h with LPS (1 μg/ml) alone or SB203580 (3 μM) in the absence or presence of LPS and the protein levels of LECT2 were measured using Western blot. (C, D) Expression of p-p38 protein level in AML12 cells treated with LPS (1 μg/ml) in the presence or absence of the TLR4 inhibitor TAK-242 (3 μM) for 6 h. Western blot analysis showing differential expression of p-p38 and p38 and their quantification normalized against p38. (E, F) The expression levels of LECT2 protein and mRNA levels in AML12 cells treated with various concentrations of anisomycin, p38 activator for 6 h. The expression level of LECT2 protein and mouse Lect2 mRNA was measured by western blot with anti-LECT2 antibody and quantitative real-time polymerase chain reaction (qRT-PCR). Values of experiments are represented as mean ± SD (n = 3, independent experiments). **P < 0.01 or ****P < 0.0001 compared to control as determined by one-way ANOVA.
Article Snippet: Resatorvid (TAK-242), Adezmapimod (SB 203580), PD98059, LY294002, SP600125, BAY 11-7082, and
Techniques: Expressing, Activation Assay, Incubation, Western Blot, Quantitative Proteomics, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Control
Journal: Scientific Reports
Article Title: Histone acetylation determines transcription of atypical protein kinases in rat neurons
doi: 10.1038/s41598-019-40823-z
Figure Lengend Snippet: Blockade of translation with anisomycin (Ani, 10 μM) selectively altered the TSA-induced regulation of PKMζ and PKCζ expression, while epigenetically-driven upregulation of PKCλ expression was unaffected. ( a ) Application of Ani did not impair the TSA-induced upregulation of PKCλ expression. Control, TSA-treated (19 h) cultures and cultures treated with Ani alone (20 h) or in combinations with TSA were used for comparisons. For the last group, Ani was administered for 1 h before the application of TSA. [F (3,17) = 20,913; p < 0,001; n = 5–6/group]. ( b , c ) Ani prevented downregulation of PKMζ expression in TSA-treated cultures [KW: H (3, N = 24) = 13,22000 p = 0,0042; *p = 0,002; & p < 0,001; n = 6/group] and significantly alleviated epigenetically-driven upregulation of PKCζ expression [KW: H (3, N = 20) = 16,45893 p = 0,0009; *p < 0,001; n = 5/group]. Representative experiment below demonstrates patterns of PKCζ expression in the current experimental series. mRNA levels were determined by standard PCR followed by agarose gel electrophoresis. YWHAZ served as a reference. *Significant differences; & Significant difference (relative to standard control group); ns – not significant.
Article Snippet: Transcription inhibitor actinomycin D (ActD, final concentration 200 nM, 4 μM; Sigma-Aldrich), and
Techniques: Expressing, Control, Agarose Gel Electrophoresis
Journal: Kidney International Reports
Article Title: Structure-Activity Analysis Reveals Perturbed Cilia-Jun N-Terminal Kinase Signaling in MAPKBP1-Associated Kidney Disease
doi: 10.1016/j.ekir.2025.05.049
Figure Lengend Snippet: Influence of JNK signaling on MAPKBP1 localization to microtubular structures. (a–c) Immunofluorescence microscopy showing overall (a) intracellular and (b) centrosomal localization of GFP-tagged MAPKBP1 wild type in transiently transfected HeLa cells (GFP-MAPKBP1: green, PCNT: red, nuclei: blue) and localization of GFP-MAPKBP1 wild type at (c) the basal body of transiently transfected H69 cells (GFP-MAPKBP1: green, acetylated-α tubulin: red, nuclei: blue) upon either inhibition (JNK Inh VIII) or activation (anisomycin) of JNK signaling pathway. Scale bars equal (a) 10 μm; (b) 1 μm; (c) 2 μm. (d) Quantification of GFP intensity at the centrosome in HeLa cells transiently transfected with GFP-MAPKBP1 wild type treated with either JNK Inh VIII or anisomycin (AM), respectively. (e) Quantification of GFP intensity at the basal body relative to the cytosol of H69 cells transiently transfected with GFP-MAPKBP1 wild type treated with either JNK Inh VIII or anisomycin (AM), respectively. (f) Quantification of transfected H69 cells presenting a primary cilium (red) and cells with GFP-MAPKBP1 localized at the basal body (green) depending on treatment with either JNK Inh VIII or anisomycin (AM). (g) Quantification of MAPKBP1 wild type in cell lysates of HEK293T cells treated with either DMSO, JNK Inh VIII or anisomycin (AM), respectively. (h) Co immunoprecipitation to quantify homodimerization of MAPKBP1 wild type depending on JNK signaling activation (AM) or inhibition (JNK Inh VIII). (i) Immunofluorescence microscopy of HeLa cells transiently cotransfected with RFP-tagged MAPKBP1 wild type and GFP-tagged MAPKBP1 deletion variants. Images show influence of JNK activation (anisomycin) on homodimerization and cellular localization (RFP-MAPKBP1 wild type: red; GFP-MAPKBP1 variant: green, nuclei: blue). Scale bars equal 10 μm. (j) Quantification of cellular localization pattern depending on JNK signaling activation (anisomycin). All data represent the mean (± SEM) of at least 3 independent experiments. AM, Anisomycin; GFP, green fluorescent protein; JNK Inh VIII/JI VIII, JNK inhibitor VIII; PCNT, pericentrin; RFP, red fluorescent protein; #, ##, reference for statistical testing; ∗ P ≤ 0.05; ∗∗ P ≤ 0.01; ∗∗∗ P ≤ 0.001; and ∗∗∗∗ P ≤ 0.0001.
Article Snippet: Activation of JNK signaling was induced by incubation with 25 μg/ml
Techniques: Immunofluorescence, Microscopy, Transfection, Inhibition, Activation Assay, Immunoprecipitation, Variant Assay
Journal: Kidney International Reports
Article Title: Structure-Activity Analysis Reveals Perturbed Cilia-Jun N-Terminal Kinase Signaling in MAPKBP1-Associated Kidney Disease
doi: 10.1016/j.ekir.2025.05.049
Figure Lengend Snippet: Mutual influence of JNK and MAPKBP1 in RPE1 cells and patient fibroblasts. (a) Immunofluorescence microscopy of RPE1 cells treated with either DMSO, JNK Inh VIII, anisomycin or TGFB. (b) Immunofluorescence microscopy of RPE1 cells transfected with anti- MAPKBP1 siRNA (MAPKBP1-KD) or scrambled siRNA. (a–b I) Endogenous MAPKBP1 was stained with anti-MAPKBP1 antibody (MAPKBP1: red acetylated α-tubulin: green, nuclei: blue). Scale bars equal 2 μm. (a–b II) Quantification of MAPKBP1 intensity at the basal body. (a–b II) Ciliary length. Black bordered white dots represent the mean of each independent experiment. Violin plots represent the sum of all individual datapoints. (c) Immunofluorescence microscopy of RPE1 cells transfected with anti- MAPKBP1 siRNA (MAPKBP1-KD) or scrambled siRNA and treated with either DMSO or TGFB. (I) Endogenous pJNK stained with anti-pJNK antibody (pJNK: red, acetylated α-tubulin: green, nuclei: blue). Scale bars equal 2 μm. (II) Quantification of pJNK intensity at the basal body depending on TGFB treatment. (III) Quantification of nuclear pJNK. (d) Immunofluorescence microscopy of primary fibroblasts of a healthy control individual treated with either DMSO, JNK Inh VIII, anisomycin (AM). (I) Endogenous MAPKBP1 stained with anti-MAPKBP1 antibody (MAPKBP1: red, acetylated α-tubulin: green, nuclei: blue). Scale bars equal 2 μm. (II) Quantification of MAPKBP1 intensity at the basal body. (III) Ciliary length. Black bordered white dots represent the mean of each independent experiment. Violin plots represent the sum of all individual datapoints. (e) Immunofluorescence microscopy of endogenous MAPKBP1 at the basal body of primary cilia in primary fibroblasts from a healthy control individual and a NPHP20 patient. (I) Endogenous MAPKBP1 was stained with primary anti-MAPKBP1 antibody (MAPKBP1: red, acetylated α-tubulin: green, nuclei: blue). Scale bars equal 2 μm. (II) Quantification of pJNK intensities at the basal body in dermal fibroblasts from healthy control individuals I and II, and NPHP20 patients I, II, and V. (III) Quantification of nuclear pJNK in dermal fibroblasts of healthy control I and II and NPHP20 patients I, II, and V. (IV) Ciliary length of primary cells derived from healthy control individuals I and II and NPHP20 patients I, II, and V with and without treatment with 250 nM cytochalasin D. Data are mean ± SEM of the mean values of at least 3 independent experiments. All data represent the mean ± SEM of at least 3 independent experiments. AM, Anisomycin; DMSO, dimethyl sulfoxide; JNK Inh VIII/JI VIII, JNK inhibitor VIII; siRNA, small interfering RNA; TGFB, transforming growth factor beta; #, ##, reference for statistical testing; ∗ P ≤ 0.05; ∗∗ P ≤ 0.01; ∗∗∗ P ≤ 0.001; and ∗∗∗∗ P ≤ 0.0001.
Article Snippet: Activation of JNK signaling was induced by incubation with 25 μg/ml
Techniques: Immunofluorescence, Microscopy, Transfection, Staining, Control, Derivative Assay, Small Interfering RNA